@article{chow_ministry_2011,
	title = {Ministry of health clinical practice guidelines: {Chronic} hepatitis {B} infection},
	volume = {52},
	issn = {0037-5675},
	url = {http://smj.sma.org.sg/5204/5204cpg1.pdf http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361924652},
	abstract = {The Ministry of Health (MOH) publishes clinicalpractice guidelines on Chronic Hepatitis B Infection to provide doctors and patients in Singapore with evidence-based guidance on managing important medical conditions. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH clinical practice guidelines on Chronic Hepatitis B Infection, for the information of readers of the Singapore Medical Journal. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website (http://www.moh.gov.sg/mohcorp/publications.aspx?id=26108). The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.},
	language = {English},
	number = {4},
	journal = {Singapore Medical Journal},
	author = {Chow, W. C. and Chong, R. and Guan, R. and Ho, H. K. L. and Leo, Y. S. and Loy, K. L. and Lui, H. F. and Ng, H. S. and Siew, W. F. and Teo, E. K. and Yeo, T.},
	year = {2011},
	keywords = {*hepatitis B/di [Diagnosis], *hepatitis B/dt [Drug Therapy], *hepatitis B/ep [Epidemiology], *practice guideline, Singapore, alpha interferon/dt [Drug Therapy], anamnesis, article, evidence based medicine, hepatitis B vaccine/dt [Drug Therapy], hepatitis B/dt [Drug Therapy], high risk population, human, liver cell carcinoma, liver cirrhosis, nucleoside analog/dt [Drug Therapy], nucleotide derivative/dt [Drug Therapy], physical examination, screening, vaccination},
	pages = {307--313},
}

{"_id":"fScp6S6auuxBuNQ2x","bibbaseid":"chow-chong-guan-ho-leo-loy-lui-ng-etal-ministryofhealthclinicalpracticeguidelineschronichepatitisbinfection-2011","authorIDs":[],"author_short":["Chow, W. C.","Chong, R.","Guan, R.","Ho, H. K. L.","Leo, Y. S.","Loy, K. L.","Lui, H. F.","Ng, H. S.","Siew, W. F.","Teo, E. K.","Yeo, T."],"bibdata":{"bibtype":"article","type":"article","title":"Ministry of health clinical practice guidelines: Chronic hepatitis B infection","volume":"52","issn":"0037-5675","url":"http://smj.sma.org.sg/5204/5204cpg1.pdf http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361924652","abstract":"The Ministry of Health (MOH) publishes clinicalpractice guidelines on Chronic Hepatitis B Infection to provide doctors and patients in Singapore with evidence-based guidance on managing important medical conditions. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH clinical practice guidelines on Chronic Hepatitis B Infection, for the information of readers of the Singapore Medical Journal. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website (http://www.moh.gov.sg/mohcorp/publications.aspx?id=26108). The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.","language":"English","number":"4","journal":"Singapore Medical Journal","author":[{"propositions":[],"lastnames":["Chow"],"firstnames":["W.","C."],"suffixes":[]},{"propositions":[],"lastnames":["Chong"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Guan"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Ho"],"firstnames":["H.","K.","L."],"suffixes":[]},{"propositions":[],"lastnames":["Leo"],"firstnames":["Y.","S."],"suffixes":[]},{"propositions":[],"lastnames":["Loy"],"firstnames":["K.","L."],"suffixes":[]},{"propositions":[],"lastnames":["Lui"],"firstnames":["H.","F."],"suffixes":[]},{"propositions":[],"lastnames":["Ng"],"firstnames":["H.","S."],"suffixes":[]},{"propositions":[],"lastnames":["Siew"],"firstnames":["W.","F."],"suffixes":[]},{"propositions":[],"lastnames":["Teo"],"firstnames":["E.","K."],"suffixes":[]},{"propositions":[],"lastnames":["Yeo"],"firstnames":["T."],"suffixes":[]}],"year":"2011","keywords":"*hepatitis B/di [Diagnosis], *hepatitis B/dt [Drug Therapy], *hepatitis B/ep [Epidemiology], *practice guideline, Singapore, alpha interferon/dt [Drug Therapy], anamnesis, article, evidence based medicine, hepatitis B vaccine/dt [Drug Therapy], hepatitis B/dt [Drug Therapy], high risk population, human, liver cell carcinoma, liver cirrhosis, nucleoside analog/dt [Drug Therapy], nucleotide derivative/dt [Drug Therapy], physical examination, screening, vaccination","pages":"307–313","bibtex":"@article{chow_ministry_2011,\n\ttitle = {Ministry of health clinical practice guidelines: {Chronic} hepatitis {B} infection},\n\tvolume = {52},\n\tissn = {0037-5675},\n\turl = {http://smj.sma.org.sg/5204/5204cpg1.pdf http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361924652},\n\tabstract = {The Ministry of Health (MOH) publishes clinicalpractice guidelines on Chronic Hepatitis B Infection to provide doctors and patients in Singapore with evidence-based guidance on managing important medical conditions. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH clinical practice guidelines on Chronic Hepatitis B Infection, for the information of readers of the Singapore Medical Journal. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website (http://www.moh.gov.sg/mohcorp/publications.aspx?id=26108). The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.},\n\tlanguage = {English},\n\tnumber = {4},\n\tjournal = {Singapore Medical Journal},\n\tauthor = {Chow, W. C. and Chong, R. and Guan, R. and Ho, H. K. L. and Leo, Y. S. and Loy, K. L. and Lui, H. F. and Ng, H. S. and Siew, W. F. and Teo, E. K. and Yeo, T.},\n\tyear = {2011},\n\tkeywords = {*hepatitis B/di [Diagnosis], *hepatitis B/dt [Drug Therapy], *hepatitis B/ep [Epidemiology], *practice guideline, Singapore, alpha interferon/dt [Drug Therapy], anamnesis, article, evidence based medicine, hepatitis B vaccine/dt [Drug Therapy], hepatitis B/dt [Drug Therapy], high risk population, human, liver cell carcinoma, liver cirrhosis, nucleoside analog/dt [Drug Therapy], nucleotide derivative/dt [Drug Therapy], physical examination, screening, vaccination},\n\tpages = {307--313},\n}\n\n","author_short":["Chow, W. C.","Chong, R.","Guan, R.","Ho, H. K. L.","Leo, Y. S.","Loy, K. L.","Lui, H. F.","Ng, H. S.","Siew, W. F.","Teo, E. K.","Yeo, T."],"key":"chow_ministry_2011","id":"chow_ministry_2011","bibbaseid":"chow-chong-guan-ho-leo-loy-lui-ng-etal-ministryofhealthclinicalpracticeguidelineschronichepatitisbinfection-2011","role":"author","urls":{"Paper":"http://smj.sma.org.sg/5204/5204cpg1.pdf http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361924652"},"keyword":["*hepatitis B/di [Diagnosis]","*hepatitis B/dt [Drug Therapy]","*hepatitis B/ep [Epidemiology]","*practice guideline","Singapore","alpha interferon/dt [Drug Therapy]","anamnesis","article","evidence based medicine","hepatitis B vaccine/dt [Drug Therapy]","hepatitis B/dt [Drug Therapy]","high risk population","human","liver cell carcinoma","liver cirrhosis","nucleoside analog/dt [Drug Therapy]","nucleotide derivative/dt [Drug Therapy]","physical examination","screening","vaccination"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/vincentwntu","creationDate":"2020-01-26T03:06:33.985Z","downloads":0,"keywords":["*hepatitis b/di [diagnosis]","*hepatitis b/dt [drug therapy]","*hepatitis b/ep [epidemiology]","*practice guideline","singapore","alpha interferon/dt [drug therapy]","anamnesis","article","evidence based medicine","hepatitis b vaccine/dt [drug therapy]","hepatitis b/dt [drug therapy]","high risk population","human","liver cell carcinoma","liver cirrhosis","nucleoside analog/dt [drug therapy]","nucleotide derivative/dt [drug therapy]","physical examination","screening","vaccination"],"search_terms":["ministry","health","clinical","practice","guidelines","chronic","hepatitis","infection","chow","chong","guan","ho","leo","loy","lui","ng","siew","teo","yeo"],"title":"Ministry of health clinical practice guidelines: Chronic hepatitis B infection","year":2011,"dataSources":["icTw8KRRMMANXJHRd"]}